InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
InMode (Nasdaq: INMD), a leading global provider of innovative medical technologies, has announced its participation in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference. The event will take place in Snowbird, Utah on Wednesday, February 12, 2025.
The company's Chief Financial Officer, Yair Malca, will be available for investor meetings during the conference. Interested investors can arrange meetings through their BTIG sales representatives. Additional information about the event can be accessed through InMode's investor relations website.
InMode (Nasdaq: INMD), un fornitore globale leader di tecnologie mediche innovative, ha annunciato la sua partecipazione alla Conferenza BTIG MedTech, Salute Digitale, Scienze della Vita e Strumenti Diagnostici. L'evento si svolgerà a Snowbird, Utah, mercoledì 12 febbraio 2025.
Il Direttore Finanziario dell'azienda, Yair Malca, sarà disponibile per incontri con gli investitori durante la conferenza. Gli investitori interessati possono organizzare incontri tramite i loro rappresentanti di vendita BTIG. Maggiori informazioni sull'evento possono essere consultate attraverso il sito web delle relazioni con gli investitori di InMode.
InMode (Nasdaq: INMD), un proveedor global líder de tecnologías médicas innovadoras, ha anunciado su participación en la Conferencia BTIG MedTech, Salud Digital, Ciencias de la Vida y Herramientas de Diagnóstico. El evento se llevará a cabo en Snowbird, Utah el miércoles 12 de febrero de 2025.
El Director Financiero de la compañía, Yair Malca, estará disponible para reuniones con inversores durante la conferencia. Los inversores interesados pueden organizar reuniones a través de sus representantes de ventas de BTIG. Se puede acceder a información adicional sobre el evento a través del sitio web de relaciones con inversores de InMode.
InMode (Nasdaq: INMD), 혁신적인 의료 기술의 글로벌 선두 제공업체가 BTIG 메드텍, 디지털 헬스, 생명과학 및 진단 도구 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 2월 12일 수요일 유타주 스노우버드에서 개최됩니다.
회사의 최고재무책임자(CFO) Yair Malca는 컨퍼런스 동안 투자자 회의에 참석할 예정입니다. 관심 있는 투자자는 BTIG 판매 대표를 통해 회의를 조정할 수 있습니다. 행사에 대한 추가 정보는 InMode의 투자자 관계 웹사이트를 통해 확인할 수 있습니다.
InMode (Nasdaq: INMD), un fournisseur mondial leader en technologies médicales innovantes, a annoncé sa participation à la Conférence BTIG MedTech, Santé Numérique, Sciences de la Vie et Outils Diagnostiques. L'événement aura lieu à Snowbird, Utah, le mercredi 12 février 2025.
Le Directeur Financier de l'entreprise, Yair Malca, sera disponible pour des réunions avec les investisseurs durant la conférence. Les investisseurs intéressés peuvent organiser des réunions par le biais de leurs représentants commerciaux BTIG. Des informations supplémentaires sur l'événement sont accessibles via le site web des relations avec les investisseurs d'InMode.
InMode (Nasdaq: INMD), ein führender globaler Anbieter innovativer Medizintechnologien, hat seine Teilnahme an der BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference angekündigt. Die Veranstaltung findet am Mittwoch, den 12. Februar 2025 in Snowbird, Utah statt.
Der Finanzvorstand des Unternehmens, Yair Malca, wird während der Konferenz für Investorengespräche zur Verfügung stehen. Interessierte Investoren können Treffen über ihre BTIG-Verkaufsteam arrangeieren. Weitere Informationen zur Veranstaltung sind auf der Investor Relations-Website von InMode verfügbar.
- None.
- None.
YOKNEAM,

Interested investors are welcome to contact their BTIG salesperson and schedule a meeting.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-the-btig-medtech-digital-health-life-sciences--diagnostics-tools-conference-302365604.html
SOURCE InMode LTD
FAQ
When is InMode (INMD) participating in the BTIG MedTech Conference 2025?
Who will represent InMode (INMD) at the BTIG MedTech Conference 2025?
How can investors schedule meetings with InMode (INMD) at the BTIG Conference?